Regulation S-K

Form 8.3 - The Vanguard Group, Inc.: Aon plc

Retrieved on: 
Wednesday, March 10, 2021
Financial law, Stock market, Security, Derivative, Electronic voting, Finance, Group decision-making, Articles, Regulation S-K

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.

Key Points: 
  • Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.
  • If none, this should be stated.

Form 8.3 - The Vanguard Group, Inc.: Willis Towers Watson plc

Retrieved on: 
Wednesday, March 10, 2021
Financial law, Stock market, Security, Derivative, Electronic voting, Finance, Group decision-making, Articles, Regulation S-K

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.

Key Points: 
  • Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.
  • If none, this should be stated.

Northern Oil and Gas, Inc. Announces Purchase Price Reduction for Pending Reliance Acquisition

Retrieved on: 
Wednesday, March 10, 2021
Oil, Gas, Energy, Communication, Forward-looking statement, SEC filings, United States securities law, Regulation S-K

More information about Northern Oil and Gas, Inc. can be found at www.NorthernOil.com .

Key Points: 
  • More information about Northern Oil and Gas, Inc. can be found at www.NorthernOil.com .
  • Additional information concerning potential factors that could affect future financial results is included in the section entitled Item 1A.
  • Northern has based these forward-looking statements on its current expectations and assumptions about future events.
  • Northern does not undertake any duty to update or revise any forward-looking statements, except as may be required by the federal securities laws.

Xenon Pharmaceuticals Announces Pricing of $100.0 Million Public Offering

Retrieved on: 
Wednesday, March 10, 2021
Corporate finance, Financial economics, Finance, Money, Initial public offering, Stock market, Options, Public offering, Underwriting, Warrant, Xenon, Regulation S-K

The common shares are being offered at a public offering price of $18.50 per common share and the pre-funded warrants are being offered at a price of $18.4999 per pre-funded warrant.

Key Points: 
  • The common shares are being offered at a public offering price of $18.50 per common share and the pre-funded warrants are being offered at a price of $18.4999 per pre-funded warrant.
  • The gross proceeds to Xenon from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Xenon, are expected to be approximately $100.0 million.
  • In addition, Xenon has granted to the underwriters of the offering an option for a period of 30 days to purchase up to an additional 810,810 common shares at the public offering price, less the underwriting discounts and commissions.
  • These forward-looking statements are not based on historical fact and include statements regarding the anticipated closing of the public offering.

Form 8.3 - The Vanguard Group, Inc.: Aon plc

Retrieved on: 
Tuesday, March 9, 2021
Financial law, Stock market, Security, Derivative, Electronic voting, Finance, Group decision-making, Articles, Regulation S-K

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.

Key Points: 
  • Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.
  • If none, this should be stated.

Form 8.3 - The Vanguard Group, Inc.: Willis Towers Watson plc

Retrieved on: 
Tuesday, March 9, 2021
Financial law, Stock market, Security, Derivative, Electronic voting, Finance, Group decision-making, Articles, Regulation S-K

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.

Key Points: 
  • Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.
  • If none, this should be stated.

Form 8.3 - The Vanguard Group, Inc.: Aon plc

Retrieved on: 
Monday, March 8, 2021
Financial law, Stock market, Security, Derivative, Electronic voting, Finance, Group decision-making, Articles, Regulation S-K

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.

Key Points: 
  • Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.
  • If none, this should be stated.

Form 8.3 - The Vanguard Group, Inc.: Willis Towers Watson plc

Retrieved on: 
Monday, March 8, 2021
Financial law, Stock market, Security, Derivative, Electronic voting, Finance, Group decision-making, Articles, Regulation S-K

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.

Key Points: 
  • Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.
  • If none, this should be stated.

Medigus Announces Exercise and Closing of Underwriter’s Over-Allotment Option

Retrieved on: 
Monday, March 8, 2021
SEC filings, Financial markets, Finance, Federal government of the United States, Prospectus, Registration statement, U.S. Securities and Exchange Commission, Red herring prospectus, Regulation S-K

Total gross proceeds to the Company from the offering, including the funds received from the prior closing and exercise of this option, are approximately $9.7 million, before deducting underwriting discounts, commissions and other offering expenses payable by the Company.

Key Points: 
  • Total gross proceeds to the Company from the offering, including the funds received from the prior closing and exercise of this option, are approximately $9.7 million, before deducting underwriting discounts, commissions and other offering expenses payable by the Company.
  • The offering was made pursuant to an F-3 registration statement previously filed with and declared effective by the Securities and Exchange Commission (SEC).
  • A final prospectus and accompany registration statement relating to the offering were filed with the SEC and are available on the SECs website at www.sec.gov.
  • Other risk factors affecting Medigus are discussed in detail in Medigus filings with the Securities and Exchange Commission.

Hudbay Completes Offering of US$600 Million of 4.50% Senior Notes due 2026 and Proceeds with Redemption of US$600 Million of 7.625% Senior Notes due 2025

Retrieved on: 
Monday, March 8, 2021
Financial markets, U.S. Securities and Exchange Commission, 73rd United States Congress, Stock market, Initial public offering, Agencies of the United States government, Securities Act, Prospectus, United States Securities Regulation, Finance, Security, Regulation S-K

Hudbay intends to use the net proceeds of the offering of the New Notes, together with available cash on hand, to finance the redemption of the companys US$600 million of 7.625% Senior Notes due 2025 (the 2025 Notes).

Key Points: 
  • Hudbay intends to use the net proceeds of the offering of the New Notes, together with available cash on hand, to finance the redemption of the companys US$600 million of 7.625% Senior Notes due 2025 (the 2025 Notes).
  • The New Notes will not be registered under the U.S. Securities Act of 1933, as amended (the Securities Act), or the securities laws of any other jurisdiction.
  • The New Notes will not be qualified by a prospectus in Canada.
  • All information contained in this news release, other than statements of current and historical fact, is forward-looking information.